Email
Print
1. Orphan Drugs Market - Overview
1.1 Definitions and Scope
2. Orphan Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Orphan Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Orphan Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Orphan Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Orphan Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Orphan Drugs Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Orphan Drugs Market - By Product Type (Market Size -$Million / $Billion)
9. Orphan Drugs Market - By Disease Type (Market Size -$Million / $Billion)
9.1 Oncologic Disease
9.2 Metabolic Disease
9.3 Hematologic And Immunologic Disease
9.4 Infectious Disease
9.5 Neurologic Disease
9.6 Other Rare Disease
10. Orphan Drugs - By Indication (Market Size -$Million / $Billion)
10.1 Non-Hodgkin Lymphoma
10.2 Acute Myeloid Leukemia
10.3 Cystic Fibrosis
10.4 Glioma
10.5 Pancreatic Cancer
10.6 Ovarian Cancer
10.7 Multiple Myeloma
10.8 Duchenne Muscular Dystrophy
10.9 Graft V Host Disease
10.10 Renal Cell Carcinoma
11. Orphan Drugs - By Geography (Market Size -$Million / $Billion)
11.1 Orphan Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Orphan Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Orphan Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Orphan Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Orphan Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Orphan Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Orphan Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Orphan Drugs Market - Key Company List by Country Premium
15. Orphan Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbvie Inc
15.3 Aegerion Pharmaceuticals, Inc
15.4 Bristol-Myers Squibb Company
15.5 Celgene Corporation
15.6 F. Hoffmann-La Roche Ag
15.7 Glaxosmithkline Plc
15.8 Johnson Johnson
15.9 Novartis Ag
15.10 Pfizer Inc
15.11 Sanofi
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Orphan Drugs Market - Appendix
16.1 Abbreviations
16.2 Sources
17. Orphan Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)1.1 Oncologic Disease Market 2023-2030 ($M) - Global Industry Research
1.2 Metabolic Disease Market 2023-2030 ($M) - Global Industry Research
1.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Global Industry Research
1.4 Infectious Disease Market 2023-2030 ($M) - Global Industry Research
1.5 Neurologic Disease Market 2023-2030 ($M) - Global Industry Research
2.Global Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
2.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Global Industry Research
2.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Global Industry Research
2.3 Cystic Fibrosis Market 2023-2030 ($M) - Global Industry Research
2.4 Glioma Market 2023-2030 ($M) - Global Industry Research
2.5 Pancreatic Cancer Market 2023-2030 ($M) - Global Industry Research
2.6 Ovarian Cancer Market 2023-2030 ($M) - Global Industry Research
2.7 Multiple Myeloma Market 2023-2030 ($M) - Global Industry Research
2.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Global Industry Research
2.9 Graft V Host Disease Market 2023-2030 ($M) - Global Industry Research
2.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Global Industry Research
3.Global Japan Orphan Drug Market, By Disease Type Market 2023-2030 (Volume/Units)
3.1 Oncologic Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Metabolic Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Hematologic And Immunologic Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Infectious Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.5 Neurologic Disease Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Japan Orphan Drug Market, By Indication Market 2023-2030 (Volume/Units)
4.1 Non-Hodgkin Lymphoma Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Acute Myeloid Leukemia Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Cystic Fibrosis Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Glioma Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Pancreatic Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.6 Ovarian Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.7 Multiple Myeloma Market 2023-2030 (Volume/Units) - Global Industry Research
4.8 Duchenne Muscular Dystrophy Market 2023-2030 (Volume/Units) - Global Industry Research
4.9 Graft V Host Disease Market 2023-2030 (Volume/Units) - Global Industry Research
4.10 Renal Cell Carcinoma Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)
5.1 Oncologic Disease Market 2023-2030 ($M) - Regional Industry Research
5.2 Metabolic Disease Market 2023-2030 ($M) - Regional Industry Research
5.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Regional Industry Research
5.4 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
5.5 Neurologic Disease Market 2023-2030 ($M) - Regional Industry Research
6.North America Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
6.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Regional Industry Research
6.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Regional Industry Research
6.3 Cystic Fibrosis Market 2023-2030 ($M) - Regional Industry Research
6.4 Glioma Market 2023-2030 ($M) - Regional Industry Research
6.5 Pancreatic Cancer Market 2023-2030 ($M) - Regional Industry Research
6.6 Ovarian Cancer Market 2023-2030 ($M) - Regional Industry Research
6.7 Multiple Myeloma Market 2023-2030 ($M) - Regional Industry Research
6.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Regional Industry Research
6.9 Graft V Host Disease Market 2023-2030 ($M) - Regional Industry Research
6.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Regional Industry Research
7.South America Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)
7.1 Oncologic Disease Market 2023-2030 ($M) - Regional Industry Research
7.2 Metabolic Disease Market 2023-2030 ($M) - Regional Industry Research
7.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Regional Industry Research
7.4 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
7.5 Neurologic Disease Market 2023-2030 ($M) - Regional Industry Research
8.South America Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
8.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Regional Industry Research
8.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Regional Industry Research
8.3 Cystic Fibrosis Market 2023-2030 ($M) - Regional Industry Research
8.4 Glioma Market 2023-2030 ($M) - Regional Industry Research
8.5 Pancreatic Cancer Market 2023-2030 ($M) - Regional Industry Research
8.6 Ovarian Cancer Market 2023-2030 ($M) - Regional Industry Research
8.7 Multiple Myeloma Market 2023-2030 ($M) - Regional Industry Research
8.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Regional Industry Research
8.9 Graft V Host Disease Market 2023-2030 ($M) - Regional Industry Research
8.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Regional Industry Research
9.Europe Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)
9.1 Oncologic Disease Market 2023-2030 ($M) - Regional Industry Research
9.2 Metabolic Disease Market 2023-2030 ($M) - Regional Industry Research
9.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Regional Industry Research
9.4 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
9.5 Neurologic Disease Market 2023-2030 ($M) - Regional Industry Research
10.Europe Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
10.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Regional Industry Research
10.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Regional Industry Research
10.3 Cystic Fibrosis Market 2023-2030 ($M) - Regional Industry Research
10.4 Glioma Market 2023-2030 ($M) - Regional Industry Research
10.5 Pancreatic Cancer Market 2023-2030 ($M) - Regional Industry Research
10.6 Ovarian Cancer Market 2023-2030 ($M) - Regional Industry Research
10.7 Multiple Myeloma Market 2023-2030 ($M) - Regional Industry Research
10.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Regional Industry Research
10.9 Graft V Host Disease Market 2023-2030 ($M) - Regional Industry Research
10.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Regional Industry Research
11.APAC Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)
11.1 Oncologic Disease Market 2023-2030 ($M) - Regional Industry Research
11.2 Metabolic Disease Market 2023-2030 ($M) - Regional Industry Research
11.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Regional Industry Research
11.4 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
11.5 Neurologic Disease Market 2023-2030 ($M) - Regional Industry Research
12.APAC Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
12.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Regional Industry Research
12.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Regional Industry Research
12.3 Cystic Fibrosis Market 2023-2030 ($M) - Regional Industry Research
12.4 Glioma Market 2023-2030 ($M) - Regional Industry Research
12.5 Pancreatic Cancer Market 2023-2030 ($M) - Regional Industry Research
12.6 Ovarian Cancer Market 2023-2030 ($M) - Regional Industry Research
12.7 Multiple Myeloma Market 2023-2030 ($M) - Regional Industry Research
12.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Regional Industry Research
12.9 Graft V Host Disease Market 2023-2030 ($M) - Regional Industry Research
12.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Regional Industry Research
13.MENA Japan Orphan Drug Market, By Disease Type Market 2023-2030 ($M)
13.1 Oncologic Disease Market 2023-2030 ($M) - Regional Industry Research
13.2 Metabolic Disease Market 2023-2030 ($M) - Regional Industry Research
13.3 Hematologic And Immunologic Disease Market 2023-2030 ($M) - Regional Industry Research
13.4 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
13.5 Neurologic Disease Market 2023-2030 ($M) - Regional Industry Research
14.MENA Japan Orphan Drug Market, By Indication Market 2023-2030 ($M)
14.1 Non-Hodgkin Lymphoma Market 2023-2030 ($M) - Regional Industry Research
14.2 Acute Myeloid Leukemia Market 2023-2030 ($M) - Regional Industry Research
14.3 Cystic Fibrosis Market 2023-2030 ($M) - Regional Industry Research
14.4 Glioma Market 2023-2030 ($M) - Regional Industry Research
14.5 Pancreatic Cancer Market 2023-2030 ($M) - Regional Industry Research
14.6 Ovarian Cancer Market 2023-2030 ($M) - Regional Industry Research
14.7 Multiple Myeloma Market 2023-2030 ($M) - Regional Industry Research
14.8 Duchenne Muscular Dystrophy Market 2023-2030 ($M) - Regional Industry Research
14.9 Graft V Host Disease Market 2023-2030 ($M) - Regional Industry Research
14.10 Renal Cell Carcinoma Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Japan Orphan Drugs Market Revenue, 2023-2030 ($M)2.Canada Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
3.Mexico Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
4.Brazil Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
5.Argentina Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
6.Peru Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
7.Colombia Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
8.Chile Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
9.Rest of South America Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
10.UK Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
11.Germany Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
12.France Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
13.Italy Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
14.Spain Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
15.Rest of Europe Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
16.China Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
17.India Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
18.Japan Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
19.South Korea Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
20.South Africa Japan Orphan Drugs Market Revenue, 2023-2030 ($M)
21.North America Japan Orphan Drugs By Application
22.South America Japan Orphan Drugs By Application
23.Europe Japan Orphan Drugs By Application
24.APAC Japan Orphan Drugs By Application
25.MENA Japan Orphan Drugs By Application
26.Abbvie Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Aegerion Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Celgene Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)